Source: Nasdaq

GeneDX: Why GeneDx Holdings Stock Is Plunging Today

Shares of GeneDx Holdings (NASDAQ: WGS) were plunging 42.9% as of 11:21 a.m. ET on Wednesday. The steep decline came after the genetic diagnostics company announced its 2025 first-quarter earnings before the market opened.

Read full article »
Annual Revenue
$100-500M
Employees
1.0-5.0K
Katherine Stueland's photo - President & CEO of GeneDX

President & CEO

Katherine Stueland

CEO Approval Rating

81/100

Read more